Cover Danny Yeung (left), founder, CEO and chairman of Prenetics, and co-founder of IM8; David Beckham, football legend, entrepreneur and philanthropist, and co-founder of IM8. (Photo: courtesy of Prenetics)
Danny Yeung (left), founder, CEO and chairman of Prenetics, and co-founder of IM8; David Beckham, football legend, entrepreneur and philanthropist, and co-founder of IM8. (Photo: courtesy of Prenetics)
1 / 1
Known for its all-in-one nutritional supplement powders targeting health, wellness and longevity, IM8 is set to accelerate its global sales footprint
Prenetics, the Nasdaq-listed consumer health company behind direct-to-consumer premium supplement brand IM8, has secured up to US$1 billion in growth financing from global VC firm General Catalyst’s Customer Value Fund (CVF).
As part of the deal, CVF will fund up to 70 per cent of IM8’s monthly marketing spend in exchange for a capped return, calculated based on each month’s “cohort” of newly acquired customers. The fresh capital will enable IM8 to “invest more aggressively in brand and marketing,” according to a statement by Prenetics.
“For a year, investors have asked whether we were spending too much on customer acquisition,” said Danny Yeung, CEO of Prenetics and co-founder of IM8, in a statement about the financing. “Now the proof is public: every dollar we have ever spent acquiring customers has already returned US$1.44 in gross profit—and that number rises every month, because these are subscribers. The right question was never whether we were spending too much; it’s whether we were spending enough.”
Yeung, a Tatler's Asia's Most Influential honouree who co-founded Prenetics in 2014 and took it public in 2022, said he faced “the deepest diligence process I’ve been through as a founder” for General Catalyst’s CVF.
“Our ambition is to build a multi-billion-dollar global consumer health brand,” he added. “This partnership materially accelerates that path.”
Read more: Tatler Exclusive: David Beckham Partners with Prenetics to Launch IM8
The financing follows a period of rapid growth for IM8. Co-founded in December 2024 by Yeung and English football legend David Beckham, IM8 generated approximately US$33.8 million in revenue in the first quarter of 2026, a year-over-year increase of nearly sixfold, according to Prenetics. Backed by strong performance in the first half of the year—including a record-breaking June, in which IM8 reported approximately US$17 million in monthly revenue—Prenetics expects IM8 to reach an annualised run-rate revenue of approximately US$300 million by the end of 2026.
“IM8 is a category-defining consumer health business, and the underlying cohort economics are among the strongest we’ve seen across the Customer Value Fund portfolio,” said Adit Swarup, a partner at General Catalyst who led the deal, in a statement. “Their cohort retention data is remarkable: highly consistent across geographies, subscription tenors, and product lines, with quarterly renewal rates setting new industry benchmarks for direct-to-consumer health.”
Read more: David Beckham and Prenetics Officially Launch IM8, All-in-One Supplement
Above Danny Yeung (left) and David Beckham. The pair launched IM8 in 2024; they first met in 2023 through their mutual friend Michel Lamunière, the chairman and CEO of Tatler Asia and publisher of Tatler Hong Kong. (Photo: courtesy of Prenetics)
Danny Yeung (left) and David Beckham. The pair launched IM8 in 2024; they first met in 2023 through their mutual friend Michel Lamunière, the chairman and CEO of Tatler Asia and publisher of Tatler Hong Kong. (Photo: courtesy of Prenetics)
1 / 1
Operating separately from its seed and growth-stage venture funds, General Catalyst's CVF is designed for larger, established companies that have already found product-market fit. Financing from CVF essentially acts as non-dilutive capital for a company's sales and marketing or customer acquisition costs. In May 2025, writing software company Grammarly secured US$1 billion in growth financing from CVF, and in June 2025, healthcare AI company Commure secured US$200 million.
Prenetics noted that it would record the IM8 facility as a financial liability on its balance sheet rather than debt, with the return component booked as interest expense below operating income. While Prenetics reported a loss from operations of US$8.9 million and an adjusted EBITDA loss of US$5.6 million for the first quarter of 2026, the company has since bolstered its cash position by fully divesting its digital asset holdings and has continued its US$40 million share buyback programme.
Read more: NBA champion Giannis Antetokounmpo takes an equity stake in health brand IM8
Known for its two flagship products, the all-in-one powdered multivitamin drink mix Daily Ultimate Essentials and Daily Ultimate Longevity, IM8 has reported selling a total of 50 million servings to date. The brand is also planning to launch an IM8 Hydration product in the fourth quarter of 2026 and a premium wellness gummies line in the first quarter of 2027.
Boosting IM8’s sales is its roster of celebrity athlete partners and brand ambassadors, including Beckham, tennis star Aryna Sabalenka, basketball player Giannis Antetokounmpo, and Formula 1 driver Ollie Bearman. In May 2026, IM8 also inked a multi-year partnership with Inter Miami CF—the global football club co-owned by Beckham—that includes an IM8 Nutrition Centre at the club’s training facility and name, image, and likeness rights covering at least four club players.
Cat Wang is an editor at Tatler Asia based in Hong Kong, where she covers business, wealth, innovation, and impact. Previously, she was a Forbes Asia reporter and assistant editor of the Forbes Asia 100 to Watch list, spotlighting startups and small companies on the rise across the Asia-Pacific. She began her career as a trainee reporter at the South China Morning Post, Hong Kong’s newspaper of record. Born in New York City, she graduated from the University of California, Los Angeles, with a B.A. in political science.
